ADMA
ADMA Biologics, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +5.6% ·
aandelenstroom -2.5% ·
netto nieuwe posities 0.0%
· formule
Fragmentatie van eigendom: meer houders, kleiner totaalbelang
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 105 | -1 | 146.16M | $1.22B | +9 | −12 |
| Q1 2026 | 111 | -5 | 163.83M | $1.48B | +7 | −12 |
| Q4 2025 | 115 | +1 | 163.64M | $2.98B | +1 | n/a |
| Q3 2025 | 19 | +1 | 92.34M | $1.35B | +3 | −3 |
| Q2 2025 | 16 | -1 | 89.41M | $1.63B | +1 | −2 |
| Q1 2025 | 14 | 0 | 31.71M | $629.12M | n/a | n/a |
| Q4 2024 | 14 | +2 | 37.00M | $634.64M | +2 | n/a |
| Q3 2024 | 11 | -2 | 23.86M | $476.89M | n/a | −2 |
| Q2 2024 | 13 | n/a | 23.97M | $268.00M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 35.63M | -2.3% | $522.36M | 0.0% | ▼ Trim | 2 | SEC ↗ ×15 |
| 2 | The Vanguard Group ✦ (passief) | 20.97M | -1.8% | $307.49M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (passief) | 13.56M | +12.3% | $198.81M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passief) | 5.81M | -1.7% | $85.24M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 5 | Goldman Sachs Group ✦ | 2.91M | n/a | $42.67M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 6 | Renaissance Technologies ✦ | 2.77M | -11.9% | $40.61M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 2.16M | +0.8% | $31.60M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Citadel Advisors ✦ | 2.12M | Nieuw | $31.07M | 0.0% | New | 1 | SEC ↗ ×2 |
| 9 | Morgan Stanley ✦ | 1.46M | n/a | $21.38M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 10 | Point72 Asset Management ✦ | 1.32M | Nieuw | $19.38M | 0.0% | New | 1 | SEC ↗ |
| 11 | JPMorgan Chase ✦ | 923.40K | n/a | $13.54M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 12 | Two Sigma Investments ✦ | 898.03K | -25.3% | $13.17M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 13 | Fidelity (FMR) ✦ | 732.66K | -77.2% | $10.74M | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 14 | D. E. Shaw & Co. ✦ | 332.70K | -60.0% | $4.88M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | Millennium Management ✦ | 284.84K | -74.9% | $4.18M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 275.16K | -40.2% | $4.03M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 17 | Wellington Management ✦ | 103.30K | -88.9% | $1.51M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 18 | Bridgewater Associates ✦ | 60.28K | Nieuw | $883,734 | 0.0% | New | 1 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 11.01K | -89.9% | $161,421 | 0.0% | ▼ Trim | 6 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Citadel Advisors | $31.07M | 0.0% |
| Point72 Asset Management | $19.38M | 0.0% |
| Bridgewater Associates | $883,734 | 0.0% |
Verlaten
| Arrowstreet Capital | $6.57M | was 0.0% |
| Norges Bank | $548,722 | was 0.0% |
| Marshall Wace | $384,048 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 355 houders, 211.31M aandelen, $1.84B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.